Cardiomyopathy - Treatment with chloroquine sulphate or chloroquine phosphate or hydroxychloroquine Factor
Last reviewed for CCPS 18 July 2007.
Preliminary questions [38034]
38035 there is some evidence that being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine may be a factor in the development or worsening of the condition under consideration.
38534 the veteran has been treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine at some time.
38036 the veteran has been treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year at some time.38039 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and VEA service for the condition under consideration.
38040 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and VEA service for the clinical onset of the condition under consideration.
38042 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and operational service for the clinical onset of the condition under consideration.
or
38043 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and eligible service for the clinical onset of the condition under consideration.
or
7334
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.7335
the condition under consideration permanently worsened.38041 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and VEA service for the clinical worsening of the condition under consideration.
38044 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and operational service for the clinical worsening of the condition under consideration.
or
38045 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and eligible service for the clinical worsening of the condition under consideration.
Clinical onset and operational service [38042]
38046
the veteran was treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the one year before the clinical onset of the condition under consideration.38047
operational service made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the one year before the clinical onset of the condition under consideration.or
38057
the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year was materially contributed to by treatment of an illness or injury which is identifiable.38058
the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the one year before the clinical onset of the condition under consideration.38061 — the identified illness or injury which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year is causally related to operational service.
Clinical onset and eligible service [38043]
38048
the veteran has been treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years at some time.38049
the veteran was treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the two years before the clinical onset of the condition under consideration.38050
eligible service made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the two years before the clinical onset of the condition under consideration.or
38057
the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year was materially contributed to by treatment of an illness or injury which is identifiable.38059
the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years.38060
the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the two years before the clinical onset of the condition under consideration.38062 — the identified illness or injury which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years is causally related to eligible service.
Clinical worsening and operational service [38044]
38051
the veteran was treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the one year before the clinical worsening of the condition under consideration.38052
operational service made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the one year before the clinical worsening of the condition under consideration.or
38057
the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year was materially contributed to by treatment of an illness or injury which is identifiable.38063
the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the one year before the clinical worsening of the condition under consideration.38061 — the identified illness or injury which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year is causally related to operational service.
38065
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year, is causally related.Clinical worsening and eligible service [38045]
38048
the veteran has been treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years at some time.38054
the veteran was treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the two years before the clinical worsening of the condition under consideration.38055
eligible service made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the two years before the clinical worsening of the condition under consideration.or
38057
the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year was materially contributed to by treatment of an illness or injury which is identifiable.38059
the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years.38064
the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the two years before the clinical worsening of the condition under consideration.38062 — the identified illness or injury which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years is causally related to eligible service.
38066
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years, is causally related.